Yüklüyor......
The resurgence of thyromimetics as lipid-modifying agents
Aggressive reduction of LDL cholesterol by the use of statins is a cornerstone of preventive cardiovascular care, but additional therapies to prevent atherosclerosis and its clinical sequelae are still needed. Thyromimetics selective for the liver or the thyroid hormone receptor isoform β1 constitut...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2993058/ https://ncbi.nlm.nih.gov/pubmed/19705333 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|